What are the essential facts about the birth control ring, and how is it prescribed in Europe?

Birth control ring explained: combined hormonal contraception, ethinylestradiol and progestin release, efficacy rates, and prescribing criteria.

In this episode, we outline how the vaginal contraceptive ring works and how doctors assess suitability under EU medical guidance.

You’ll learn:

• What the birth control ring is (a flexible vaginal ring releasing oestrogen and progestin)

• How it prevents ovulation and thickens cervical mucus

• Typical use schedule (3 weeks in, 1 week out)

• Effectiveness when used correctly

• Common side effects: nausea, breast tenderness, spotting

• Risk factors such as venous thromboembolism (VTE)

• Who should not use combined hormonal contraception (e.g., migraine with aura, certain clotting risks)

• Situations where a prescription request may be declined based on medical history

We explain how doctors assess blood pressure, BMI, smoking status, migraine history, clotting risk, medication interactions, and personal preferences during an online consultation in the EU. Combined hormonal contraception is prescribed only when safety criteria are met.

This episode reflects the clinical standards used by Mobi Doctor, where contraceptive consultations are reviewed by a registered physician in line with EU prescribing guidance.

Read the full guide and transcript here:

https://www.mobidoctor.eu/blog/6-essential-facts-about-the-birth-control-ring